Skip to main content
Top
Published in: Acta Neurochirurgica 2/2021

01-02-2021 | Metastasis | Original Article - Tumor - Other

Incidence and prognosis of distant metastasis in malignant peripheral nerve sheath tumors

Published in: Acta Neurochirurgica | Issue 2/2021

Login to get access

Abstract

Background

Malignant peripheral nerve sheath tumors (MPNSTs) are a type of soft tissue sarcomas (STS) with recurrence and metastatic potential. We aimed to investigate the risk factors for developing distant metastases (DM) and to identify the prognostic factors in patients with DM.

Methods

Based on the Surveillance, Epidemiology, and End Result (SEER) database, MPNST patients diagnosed between 2010 and 2016 were extracted in our study. The logistic regression model was performed for predicting DM development while the Cox proportional hazard regression model was conducted for revealing the prognostic factors.

Results

Eventually, 764 patients diagnosed with MPNSTs were included with 109 cases presenting with metastases at initial diagnosis. Larger tumor size and lymph node metastases were independent risk factors for developing DM. The median overall survival (OS) for patients with metastases was 8.0 (95% CI: 6.1–9.9) months. Multiple metastatic sites and no surgical treatment were prognostic factors for worse survival. Tumors located in non-head and neck region were related with better survival.

Conclusions

The incidence of DM was 14.3% with a dismal median OS of 8.0 months for metastatic MPNSTs. More evaluation should be applied for patients with large tumor size and lymph metastases. Tumors located in head and neck region and the presence of multiple metastases predicted worse survival outcome. Surgical treatment can significantly improve the survival of MPNST patients with distant metastasis.
Literature
1.
go back to reference Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, Lozza L, Collini P, Olmi P, Casali PG, Pilotti S, Gronchi A (2006) Malignant peripheral nerve sheath tumors. Cancer-Am Cancer Soc 107:1065–1074 Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, Lozza L, Collini P, Olmi P, Casali PG, Pilotti S, Gronchi A (2006) Malignant peripheral nerve sheath tumors. Cancer-Am Cancer Soc 107:1065–1074
2.
go back to reference Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS (2014) Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer 61:1955–1960CrossRefPubMed Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS (2014) Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer 61:1955–1960CrossRefPubMed
3.
4.
go back to reference Boland JM, Colby TV, Folpe AL (2015) Intrathoracic peripheral nerve sheath tumors-a clinicopathological study of 75 cases. Hum Pathol 46:419–425CrossRefPubMed Boland JM, Colby TV, Folpe AL (2015) Intrathoracic peripheral nerve sheath tumors-a clinicopathological study of 75 cases. Hum Pathol 46:419–425CrossRefPubMed
5.
go back to reference Cariboni U, De Sanctis R, Giaretta M, Voulaz E, Morenghi E, Colombo P, Novellis P, Bottoni E, Errico V, Crepaldi A, Marrari A, Navarria P, Ascolese AM, Testori A, Scorsetti M, Quagliuolo V, Santoro A, Alloisio M (2019) Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients. Am J Clin Oncol 42:6–11CrossRefPubMed Cariboni U, De Sanctis R, Giaretta M, Voulaz E, Morenghi E, Colombo P, Novellis P, Bottoni E, Errico V, Crepaldi A, Marrari A, Navarria P, Ascolese AM, Testori A, Scorsetti M, Quagliuolo V, Santoro A, Alloisio M (2019) Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients. Am J Clin Oncol 42:6–11CrossRefPubMed
6.
go back to reference Carlson ML, Jacob JT, Habermann EB, Glasgow AE, Raghunathan A, Link MJ (2016) Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation. J Neurosurg 125:1120–1129CrossRefPubMed Carlson ML, Jacob JT, Habermann EB, Glasgow AE, Raghunathan A, Link MJ (2016) Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation. J Neurosurg 125:1120–1129CrossRefPubMed
8.
go back to reference Fuchs B, Spinner RJ, Rock MG (2005) Malignant peripheral nerve sheath tumors: an update. J Surg Orthop Adv 14:168–174PubMed Fuchs B, Spinner RJ, Rock MG (2005) Malignant peripheral nerve sheath tumors: an update. J Surg Orthop Adv 14:168–174PubMed
9.
go back to reference Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L, Han X, Lu F, Ma Y, Wang X, Wang G (2018) The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Manag Res 10:1639–1646CrossRefPubMedPubMedCentral Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L, Han X, Lu F, Ma Y, Wang X, Wang G (2018) The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer. Cancer Manag Res 10:1639–1646CrossRefPubMedPubMedCentral
10.
go back to reference Kang S, Han I, Lee S, Kim W, Kim H (2014) Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma – a comparative study with T2 (>5 cm) soft tissue sarcoma. Eur J Surg Oncol 40:406–411CrossRefPubMed Kang S, Han I, Lee S, Kim W, Kim H (2014) Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma – a comparative study with T2 (>5 cm) soft tissue sarcoma. Eur J Surg Oncol 40:406–411CrossRefPubMed
11.
go back to reference Kim W, Han I, Lee JS, Cho HS, Park JW, Kim HS (2018) Postmetastasis survival in high-grade extremity osteosarcoma: a retrospective analysis of prognostic factors in 126 patients. J Surg Oncol 117:1223–1231CrossRefPubMed Kim W, Han I, Lee JS, Cho HS, Park JW, Kim HS (2018) Postmetastasis survival in high-grade extremity osteosarcoma: a retrospective analysis of prognostic factors in 126 patients. J Surg Oncol 117:1223–1231CrossRefPubMed
12.
go back to reference Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJA, Van Glabbeke M, Hogendoorn PCW, Hohenberger P (2011) First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study. Ann Oncol 22:207–214CrossRefPubMed Kroep JR, Ouali M, Gelderblom H, Le Cesne A, Dekker TJA, Van Glabbeke M, Hogendoorn PCW, Hohenberger P (2011) First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study. Ann Oncol 22:207–214CrossRefPubMed
13.
go back to reference L'Heureux-Lebeau B, Saliba I (2013) Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors. Onco Targets Ther 6:459–470PubMedPubMedCentral L'Heureux-Lebeau B, Saliba I (2013) Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors. Onco Targets Ther 6:459–470PubMedPubMedCentral
14.
go back to reference Ma C, Ow A, Shan OH, Wu Y, Zhang C, Sun J, Ji T, Pingarron ML, Wang L (2014) Malignant peripheral nerve sheath tumours in the head and neck region: retrospective analysis of clinicopathological features and treatment outcomes. Int J Oral Maxillofac Surg 43:924–932CrossRefPubMed Ma C, Ow A, Shan OH, Wu Y, Zhang C, Sun J, Ji T, Pingarron ML, Wang L (2014) Malignant peripheral nerve sheath tumours in the head and neck region: retrospective analysis of clinicopathological features and treatment outcomes. Int J Oral Maxillofac Surg 43:924–932CrossRefPubMed
15.
go back to reference Martin E, Coert JH, Flucke UE, Slooff WM, Ho V, van der Graaf WT, van Dalen T, van de Sande M, van Houdt WJ, Grunhagen DJ, Verhoef C (2020) A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours. Eur J Cancer 124:77–87CrossRefPubMed Martin E, Coert JH, Flucke UE, Slooff WM, Ho V, van der Graaf WT, van Dalen T, van de Sande M, van Houdt WJ, Grunhagen DJ, Verhoef C (2020) A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours. Eur J Cancer 124:77–87CrossRefPubMed
16.
go back to reference Mullins BT, Hackman T (2014) Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature review. Case Rep Otolaryngol 2014:368920PubMedPubMedCentral Mullins BT, Hackman T (2014) Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature review. Case Rep Otolaryngol 2014:368920PubMedPubMedCentral
17.
go back to reference Patel TD, Shaigany K, Fang CH, Park RC, Baredes S, Eloy JA (2015) Comparative analysis of head and neck and non–head and neck malignant peripheral nerve sheath tumors. Otolaryngol Head Neck Surg 154:113–120CrossRefPubMed Patel TD, Shaigany K, Fang CH, Park RC, Baredes S, Eloy JA (2015) Comparative analysis of head and neck and non–head and neck malignant peripheral nerve sheath tumors. Otolaryngol Head Neck Surg 154:113–120CrossRefPubMed
18.
go back to reference Schmidt RF, Yick F, Boghani Z, Eloy JA, Liu JK (2013) Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases. Neurosurg Focus 34:E5CrossRefPubMed Schmidt RF, Yick F, Boghani Z, Eloy JA, Liu JK (2013) Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases. Neurosurg Focus 34:E5CrossRefPubMed
19.
go back to reference Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, Wasif N (2012) Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 19:878–885CrossRefPubMed Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, Wasif N (2012) Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 19:878–885CrossRefPubMed
20.
go back to reference Sun Z, Zheng H, Yu J, Huang W, Li T, Chen H, Hu Y, Zhao M, Liu H, Jiang Y, Li G (2019) Liver metastases in newly diagnosed gastric cancer: a population-based study from SEER. J Cancer 10:2991–3005CrossRefPubMedPubMedCentral Sun Z, Zheng H, Yu J, Huang W, Li T, Chen H, Hu Y, Zhao M, Liu H, Jiang Y, Li G (2019) Liver metastases in newly diagnosed gastric cancer: a population-based study from SEER. J Cancer 10:2991–3005CrossRefPubMedPubMedCentral
21.
go back to reference Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C (2016) Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer 56:77–84CrossRefPubMed Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C (2016) Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer 56:77–84CrossRefPubMed
22.
go back to reference Wen J, Chen J, Liu D, Xu X, Fan M, Zhang Z (2019) The eighth edition of the American Joint Committee on Cancer (AJCC) distant metastases (M) stage classification for metastatic pancreatic neuroendocrine tumors might be feasible for metastatic pancreatic ductal adenocarcinomas. Neuroendocrinology Wen J, Chen J, Liu D, Xu X, Fan M, Zhang Z (2019) The eighth edition of the American Joint Committee on Cancer (AJCC) distant metastases (M) stage classification for metastatic pancreatic neuroendocrine tumors might be feasible for metastatic pancreatic ductal adenocarcinomas. Neuroendocrinology
23.
go back to reference Widemann BC, Italiano A (2018) Biology and management of undifferentiated pleomorphic sarcoma, myxofibrosarcoma, and malignant peripheral nerve sheath tumors: state of the art and perspectives. J Clin Oncol 36:160–167CrossRefPubMed Widemann BC, Italiano A (2018) Biology and management of undifferentiated pleomorphic sarcoma, myxofibrosarcoma, and malignant peripheral nerve sheath tumors: state of the art and perspectives. J Clin Oncol 36:160–167CrossRefPubMed
24.
go back to reference Yan P, Huang R, Hu P, Liu F, Zhu X, Hu P, Yin H, Zhang J, Meng T, Huang Z (2019) Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study. J Neuro-Oncol 143:495–503CrossRef Yan P, Huang R, Hu P, Liu F, Zhu X, Hu P, Yin H, Zhang J, Meng T, Huang Z (2019) Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study. J Neuro-Oncol 143:495–503CrossRef
25.
go back to reference Zhang C, Liu L, Tao F, Guo X, Feng G, Chen F, Xu Y, Li L, Han X, Baklaushev VP, Bryukhovetskiy AS, Wang X, Wang G (2018) Bone metastases pattern in newly diagnosed metastatic bladder cancer: a population-based study. J Cancer 9:4706–4711CrossRefPubMedPubMedCentral Zhang C, Liu L, Tao F, Guo X, Feng G, Chen F, Xu Y, Li L, Han X, Baklaushev VP, Bryukhovetskiy AS, Wang X, Wang G (2018) Bone metastases pattern in newly diagnosed metastatic bladder cancer: a population-based study. J Cancer 9:4706–4711CrossRefPubMedPubMedCentral
26.
go back to reference Zhang Y, Guo X, Wang G, Ma W, Liu R, Han X, Li L, Baklaushev VP, Bryukhovetskiy AS, Wang W, Wang X, Zhang C (2018) Real-world study of the incidence, risk factors, and prognostic factors associated with bone metastases in women with uterine cervical cancer using Surveillance, Epidemiology, and End Results (SEER) data analysis. Med Sci Monit 24:6387–6397CrossRefPubMedPubMedCentral Zhang Y, Guo X, Wang G, Ma W, Liu R, Han X, Li L, Baklaushev VP, Bryukhovetskiy AS, Wang W, Wang X, Zhang C (2018) Real-world study of the incidence, risk factors, and prognostic factors associated with bone metastases in women with uterine cervical cancer using Surveillance, Epidemiology, and End Results (SEER) data analysis. Med Sci Monit 24:6387–6397CrossRefPubMedPubMedCentral
27.
go back to reference Zhang C, Guo X, Xu Y, Han X, Cai J, Wang X, Wang G (2019) Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study. Sao Paulo Med J 137:423–429CrossRefPubMed Zhang C, Guo X, Xu Y, Han X, Cai J, Wang X, Wang G (2019) Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study. Sao Paulo Med J 137:423–429CrossRefPubMed
28.
go back to reference Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D (2009) Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249:1014–1022CrossRefPubMed Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D (2009) Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249:1014–1022CrossRefPubMed
Metadata
Title
Incidence and prognosis of distant metastasis in malignant peripheral nerve sheath tumors
Publication date
01-02-2021
Published in
Acta Neurochirurgica / Issue 2/2021
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-020-04647-5

Other articles of this Issue 2/2021

Acta Neurochirurgica 2/2021 Go to the issue